glp 1 semaglutide or tirzepatide vs for Weight Loss Semaglutide vs Tirzepatide: Which GLP-1

In a 48-week Phase 2 trial published in the New England Journal of Medicine (Sanyal and colleagues, NCT04771273), 293 adults with biopsy-confirmed MASH and fibrosis stage F1 through F3 were randomized 1:1:1:1 to once-weekly subcutaneous survodutide at 2.4, 4.8, or 6.0 mg or placebo, again using a 24-week rapid escalation followed by a 24-week maintenance phase

Exercise Regimen Exercise has been shown to improve gastrointestinal motility and reduce symptoms such as bloating and abdominal discomfort

They do not offer compounded GLP-1 medications

Set a step or activity goal for the day, and hit it

doi: 10.1210/jc.2018-00070 28 MarsoSPBainSCConsoliAEliaschewitzFGJodarELeiterLAet al